Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)
Website: https://web.emmes.com/study/bmt2
Parent Study Contact:
Alan Howard,
ahoward@nmdp.org
Study Type:
Clinical Trial
Prepared on August 25, 2010
Consent: Proprietary Consent
Commercial Use Restrictions:
No
Collection Type: Proprietary Study
- See bottom of this webpage for request information
Objectives
This study is a Phase III, multi-center trial of tandem autologous transplants versus the strategy of autologous followed by HLA-matched sibling non-myeloablative allogeneic transplant. Study subjects were assigned to the appropriate arm depending on the availability of an HLA-matched sibling. There is a nested randomized phase III trial of observation versus maintenance therapy following the second autologous transplant for patients on the tandem autologous transplant arm.